P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE Read more about P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE European Patent03759395.1Filed on 2003-09-18
MODIFIED MYELIN PROTEIN MOLECULES Read more about MODIFIED MYELIN PROTEIN MOLECULES Australia2003246018Filed on 2003-09-10
MODIFIED MYELIN BASIC PROTEIN MOLECULES Read more about MODIFIED MYELIN BASIC PROTEIN MOLECULES Australia30223/00Filed on 2000-04-28
The Use Of Aerosolized Capreomycin For The Treatment Of Pulmonary Tuberculosis Read more about The Use Of Aerosolized Capreomycin For The Treatment Of Pulmonary Tuberculosis US Application 10/527,557Filed on 2005-03-10
Production of Attenuated Chimeric Respiratory Syncytial Virus Vaccines From Cloned Nucleotide Sequences Read more about Production of Attenuated Chimeric Respiratory Syncytial Virus Vaccines From Cloned Nucleotide Sequences Australia2005201040Filed on 2005-03-08
Nucleotide And Amino Acid Sequences of the Envelope 1 and Core Genes of Hepatitis C Virus Read more about Nucleotide And Amino Acid Sequences of the Envelope 1 and Core Genes of Hepatitis C Virus United Kingdom95930831.3Filed on 1995-08-15
The Crystal Structure Of Human Alpha-galactosidase And Its Applications For Fabry Disease Read more about The Crystal Structure Of Human Alpha-galactosidase And Its Applications For Fabry Disease Patent Cooperation TreatyPCT/US05/001338Filed on 2005-01-13
P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE Read more about P. ARIASI POLYPEPTIDES, P. PERNICIOSUS POLYPEPTIDES AND METHODS OF USE US Patent 7,741,437Filed on 2005-03-11
Porcine Rotovirus Reassortant Compositions Read more about Porcine Rotovirus Reassortant Compositions Patent Cooperation TreatyPCT/US2006/026901Filed on 2006-07-10
Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens Read more about Recovery of Recombinant Human Parainfluenza Virus Type 2 (HPIV2) From cDNA and Use of Recombinant HPIV2 in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against PIV and Other Human Pathogens Australia2003270824Filed on 2003-09-18